BMO Capital Markets Raises Extendicare (TSE:EXE) Price Target to C$30.00

Extendicare (TSE:EXE) had its target price upped by analysts at BMO Capital Markets from C$24.00 to C$30.00 in a research note issued on Monday,BayStreet.CA reports. BMO Capital Markets’ price objective would indicate a potential upside of 12.28% from the stock’s previous close.

Several other research analysts have also recently commented on the company. National Bank Financial boosted their target price on Extendicare from C$24.50 to C$29.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Canaccord Genuity Group lifted their price objective on Extendicare from C$20.00 to C$22.50 in a research note on Thursday, December 4th. Canadian Imperial Bank of Commerce upped their target price on shares of Extendicare from C$18.00 to C$22.00 in a research note on Thursday, November 13th. TD Securities lifted their price target on shares of Extendicare from C$15.00 to C$19.00 in a research note on Thursday, November 13th. Finally, Cormark boosted their price target on shares of Extendicare from C$25.00 to C$30.00 in a report on Wednesday, December 3rd. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of C$25.36.

Extendicare Stock Up 0.5%

EXE traded up C$0.14 during trading hours on Monday, hitting C$26.72. 261,013 shares of the company’s stock were exchanged, compared to its average volume of 320,571. The firm has a market cap of C$2.52 billion, a P/E ratio of 25.21 and a beta of 1.30. Extendicare has a 12-month low of C$12.12 and a 12-month high of C$27.44. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The firm has a 50 day moving average of C$23.08 and a 200 day moving average of C$18.80.

Extendicare (TSE:EXE) last posted its quarterly earnings results on Thursday, February 26th. The company reported C$0.29 EPS for the quarter. Extendicare had a net margin of 4.48% and a return on equity of 64.13%. The business had revenue of C$462.03 million during the quarter. Analysts predict that Extendicare will post 0.6134729 EPS for the current fiscal year.

Extendicare Company Profile

Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.